Plain-English translation of NCT07518407 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This pilot study is testing a smartphone app called SWITCH that helps people taking GLP-1 receptor agonist therapy (a weight loss medication) learn about nutrition and track their eating habits. The app includes daily food tracking and weekly lessons about healthy eating. Researchers want to see if the app is easy to use, helpful, and works well for people already using this medication.
People taking this medication for weight loss or type 2 diabetes often need guidance on what to eat to get the best results. This study is exploring whether a mobile app can provide that nutritional support and help people stick to healthy eating patterns alongside their medication.
You likely qualify if…
You likely don't qualify if…
You would use the SWITCH app for 6 weeks, tracking what you eat daily and completing weekly lessons about nutrition and healthy eating. You'll also complete health assessments at the beginning and end of the study, and participate in an interview about your experience with the app. The entire study commitment takes about 6 weeks, with most of the work done on your own smartphone.
AI-generated summary from trial data · Jul 1, 2026 · Not medical advice
United States